GSK Says Families Too Late To Amend Zofran MDL
GlaxoSmithKline attorneys on Thursday blasted an attempt by hundreds of families who blame the company's widely prescribed antiemetic for unexpected birth defects to amend their lawsuits and loop in federal investigative...To view the full article, register now.
Already a subscriber? Click here to view full article